# EDGAR Filing Document

**Accession Number:** 0001014763
**File Stem:** 0001493152-26-006721
**Filing Date:** 2026-2
**Character Count:** 15140
**Document Hash:** 12841da7e2244645bd49f6d98b045cf8
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-26-006721.hdr.sgml**: 20260213

**ACCESSION NUMBER**: 0001493152-26-006721

**CONFORMED SUBMISSION TYPE**: S-8

**PUBLIC DOCUMENT COUNT**: 16

**FILED AS OF DATE**: 20260213

**DATE AS OF CHANGE**: 20260213

**EFFECTIVENESS DATE**: 20260213

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Ainos, Inc.
- **CENTRAL INDEX KEY:** 0001014763
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 751974352
- **STATE OF INCORPORATION:** TX
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** S-8
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-293471
- **FILM NUMBER:** 26633447

**BUSINESS ADDRESS:**
- **STREET 1:** 3050 POST OAK BLVD,
- **STREET 2:** SUITE 510-T80
- **CITY:** HOUSTON
- **STATE:** TX
- **ZIP:** 77056
- **BUSINESS PHONE:** (281) 898-6586

**MAIL ADDRESS:**
- **STREET 1:** 3050 POST OAK BLVD,
- **STREET 2:** SUITE 510-T80
- **CITY:** HOUSTON
- **STATE:** TX
- **ZIP:** 77056

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** AMARILLO BIOSCIENCES INC
- **DATE OF NAME CHANGE:** 19960516

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM S-8**

**REGISTRATION STATEMENT UNDER THE** 

**SECURITIES ACT OF 1933**

---

| |
|:---|
| **AINOS, INC.** |
| (Exact Name of Registrant as Specified in Its Charter) |

---

---

| | |
|:---|:---|
| **TEXAS** | **75-1974352** |
| (State or other jurisdiction of<br> incorporation or organization) | (I.R.S. Employer<br> Identification No.) |
| **3050 Post Oak Blvd, Ste. 510-T80**<br> **Houston, TX**<br> **(281) 898-6586** | **77056** |
| (Address of Principal Executive Offices) | (Zip Code) |

---

**<u>2023 Stock Incentive Plan</u>**

(Full Title of the Plan)

**CT Corporation System**

**1999 Bryan St., Suite 900** 

**<u>Dallas, TX 75201-3136</u>**

(Name and Address of Agent For Service)

**<u>(214) 979-1172</u>**

(Telephone Number, Including Area Code, of Agent For Service)

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated file, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.:

Large Accelerated filer ☐ Accelerated filer ☐ <br> Non-accelerated filer ☒ Smaller reporting company ☒ <br> Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

**EXPLANATORY NOTE**

Ainos, Inc., a Texas corporation (the "Registrant"), filed a registration statement on Form S-8 on June 14, 2023 (File No. 333-272639), as amended by the post-effective amendment filed on July 22, 2024 (File No. 333-272639), each of which is incorporated herein by reference, to register under the Securities Act of 1933, as amended (the "Securities Act") shares of the Registrant's common stock, par value $0.01 per share (the "Common Stock"), issuable pursuant to the Ainos Inc. 2023 Stock Incentive Plan effective May 1, 2023 (the "2023 Plan") which amended and restated the Ainos, Inc. 2021 Stock Incentive Plan (the "2021 Plan"). The Registrant filed a registration statement on Form S-8 on July 22, 2024 (File No. 333-280928), incorporated herein by reference, to register under the Securities Act an additional 946,432 shares of the Registrant's Common Stock. The Registrant also filed a registration statement on Form S-8 on April 4, 2025 (File No. 333-286377), incorporated herein by reference, to register under the Securities Act an additional 3,085,477 shares of the Registrant's Common Stock. Previously, the Registrant had filed a registration statement on Form S-8 on July 7, 2022, as amended by the post-effective amendment filed on July 22, 2024 (File No. 333-266043), each of which is incorporated herein by reference, to register under the Securities Act shares of the Registrant's Common Stock issuance under the pursuant to the 2021 Plan.

**REGISTRATION OF ADDITIONAL SHARES PURSUANT TO GENERAL INSTRUCTION E**

The Registrant is filing this registration statement on Form S-8 (the "Registration Statement") pursuant to and in accordance with General Instruction E of Form S-8 to register 1,396,535 shares of Common Stock pursuant to the provisions of the 2023 Plan that provide for a discretionary increase in the number of shares reserved for issuance under such plan.

**PART II.**

**INFORMATION REQUIRED IN THE REGISTRATION STATEMENT**

**Item 3. Incorporation of Documents by Reference**

The following documents, previously filed by Ainos, Inc. (the "Registrant") with the Commission:

● The Registrant's Annual Report on [Form 10-K](https://www.sec.gov/Archives/edgar/data/1014763/000149315225009568/form10-k.htm) for the fiscal year ended December 31, 2024, filed with the Commission on March 7, 2025 (the "Annual Report");

● All other reports filed pursuant to Section 13(a) and 15(d) of the Securities Exchange Act of 1934 (the "Exchange Act"), since the end of the fiscal year covered by the Annual Report (other than information furnished rather than filed); and

● The description of the Registrant's common stock set forth in the Registrant's Registration Statement on Form 8-A, filed with the Commission on August 1, 1996 pursuant to Section 12(g) of the Exchange Act, including any amendment or report filed for the purpose of updating such description.

All documents subsequently filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act, as amended (other than any such documents or portions thereof that are deemed to have been furnished and not filed in accordance with the rules of the SEC), prior to the filing of a post-effective amendment which indicates that all securities offered have been sold or which de-registers all securities then remaining unsold, shall be deemed to be incorporated by reference in the Registration Statement and to be part thereof from the date of filing of such documents.

Any statement in a document incorporated or deemed to be incorporated by reference in this Registration Statement will be deemed to be modified or superseded to the extent that a statement contained in this Registration Statement or in any other later filed document that also is or is deemed to be incorporated by reference modifies or supersedes the statement. Any statement modified or superseded will not be deemed, except as modified or superseded, to be a part of this Registration Statement.

Under no circumstances will any information furnished under current items 2.02 or 7.01 of Form 8-K be deemed incorporated herein by reference unless such Form 8-K expressly provides to the contrary.

**Item 8. Exhibits.**

**<u>Exhibit Index</u>**

---

| | |
|:---|:---|
| **Exhibit Number** | **Description** |
| 4.1 | [Ainos, Inc. 2023 Stock Incentive Plan (incorporated by reference to Exhibit 4.1 to Ainos Inc.'s registration statement on Form S-8 filed with the SEC on June 14, 2023 (File No. 333-272639).](https://www.sec.gov/Archives/edgar/data/1014763/000165495423008010/aimd_ex41.htm) |
| 5.1\* | [Opinion of Legal Counsel](ex5-1.htm) |
| 23.1\* | [Consent of Independent Registered Public Accounting Firm](ex23-1.htm) |
| 23.2\* | [Consent of Legal Counsel (included as part of Exhibit 5.1)](ex5-1.htm) |
| 24.1\* | [Power of Attorney (included on signature page)](#Y-001) |
| 107\* | [Filing Fee Table](ex107.htm) |

---

\* Filed herewith

**SIGNATURES**

Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Taipei, Taiwan (R.O.C.), on February 13, 2026.

---

| | |
|:---|:---|
| **AINOS, INC.** | **AINOS, INC.** |
| By: | */s/ Chun-Hsien Tsai* |
|  | Chun-Hsien Tsai |
|  | Chairman of the Board, |
|  | President and Chief Executive Officer |

---

**POWER OF ATTORNEY**

Each person whose signature appears below hereby constitutes and appoints Chun-Hsien Tsai his true and lawful attorney-in-fact and agent with full power of substitution and re-substitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) and additions to this registration statement and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, and hereby grants to such attorneys-in-fact and agents full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or his substitute or substitutes may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed below by the following persons in the capacities and on the dates indicated.

---

| | | |
|:---|:---|:---|
| Signature | Title | Date |
| */s/ Chun-Hsien Tsai* | Chairman of the Board, President and Chief Executive Officer | February 13, 2026 |
| Chun-Hsien Tsai |  |  |
| */s/ Christopher Hsin-Liang Lee* | Chief Financial Officer | February 13, 2026 |
| Christopher Hsin-Liang Lee |  |  |
| */s/ Wen-Han Chang* | Director | February 13, 2026 |
| Wen-Han Chang |  |  |
| */s/ Yao-Chung Chiang* | Director | February 13, 2026 |
| Yao-Chung Chiang |  |  |
| */s/ Pao-Sheng Wei* | Director | February 13, 2026 |
| Pao-Sheng Wei |  |  |
| */s/ Ting-Chuan Lee* | Director | February 13, 2026 |
| Ting-Chuan Lee |  |  |
| */s/ Chun-Jung Tsai* | Director | February 13, 2026 |
| Chun-Jung Tsai |  |  |
| */s/ Chung-Yi Tsai* | Director | February 13, 2026 |
| Chung-Yi Tsai |  |  |

---

## Exhibit 5.1

**Exhibit 5.1**

---

| | |
|:---|:---|
| ![](ex5-1_001.jpg) | **Baker & McKenzie LLP**<br>452 Fifth Avenue<br> New York, NY 10018<br> United States<br>Tel: +1 212 626 4100<br> Fax: +1 212 310 1600<br>www.bakermckenzie.com |

---

---

| | |
|:---|:---|
| February 13, 2026 |  |
| Ainos, Inc. | By email |
| 3050 Post Oak Blvd., Ste. 510-T80 |  |
| Houston, TX 77056 |  |

---

**Ainos, Inc. Form S-8 Registration Statement**

We have acted as counsel to Ainos, Inc., a Texas corporation (the "Company"), in connection with its filing with the Securities and Exchange Commission (the "SEC") of a registration statement on Form S-8 (the "Registration Statement") under the Securities Act of 1933, as amended (the "Securities Act"), with respect to the proposed issuance of up to 1,396,535 shares of the Company's common stock, $0.01 par value per share (the "Shares") reserved for issuance pursuant to the Ainos, Inc. 2023 Stock Incentive Plan effective May 1, 2023 (the "Plan").

We have reviewed a copy of the Plan, and we have examined the originals, or photostatic or certified copies, of such records of the Company, of certificates of officers of the Company and of public documents, and such other documents as we have deemed relevant and necessary as the basis of the opinion set forth below. In such examination, we have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as photostatic or certified copies and the authenticity of the originals of such copies.

Based upon and subject to the foregoing, we are of the opinion that the Shares have been duly authorized, and when issued and sold in accordance with the terms of the Plan, will be validly issued, fully paid and non-assessable.

The opinion expressed above is limited to the Texas Business Organizations Code and the federal laws of the United States of America.

This opinion letter is limited to the matters stated herein, and no opinion is implied or may be inferred beyond the matters expressly stated. We hereby consent to the use of our opinion as herein set forth as an exhibit to the Registration Statement. In giving this consent, we do not hereby admit that we come within the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the SEC promulgated thereunder or Item 509 of Regulation S-K.

---

| |
|:---|
| Sincerely yours, |
| /s/ Baker & McKenzie LLP |

---

Baker & McKenzie LLP is a member of Baker & McKenzie International.

## Exhibit 23.1

**Exhibit 23.1**

![](ex23-1_001.jpg)

**Consent of Independent Registered Public Accounting Firm**

We hereby consent to the incorporation by reference in this Registration Statement on Form S-8 of Ainos, Inc. of our report dated March 7, 2025, relating to the financial statements of Ainos, Inc. (the "Company"), appearing in the Company's Annual Report on Form 10-K for the year ended December 31, 2024.

---

| |
|:---|
| /s/ KCCW Accountancy Corp. |
| Diamond Bar, California |
| February 13, 2026 |

---

## Ex-Filing

?xml version='1.0' encoding='ASCII'?

**Exhibit 107**

**Calculation of Filing Fee Table**

**Form S-8**

**Ainos Inc.** 

(Exact Name of Registrant as Specified in its Charter)

Newly Registered Securities

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Security**<br> **Type** | **Security**<br> **Class Title** | **Fee Calculation<br> Rule** | **Amount<br> Registered<sup>(1)</sup>** | **Proposed<br> Maximum Offering<br> Price Per Unit<sup>(2)</sup>** | **Maximum<br> Aggregate<br> Offering Price<sup>(2)</sup>** | **Fee Rate** | **Amount of<br> Registration Fee** |
| Equity | Common <br>Stock | Rule 457(c) <br> and Rule <br> 457(h) | 1396535 | $1.81 | $2527728.35 | 0.00013810 | $349.08 |
| **Total Offering Amounts** | **Total Offering Amounts** | **Total Offering Amounts** | **Total Offering Amounts** |  | $2527728.35 |  | $349.08 |
| **Total Fee Offsets** | **Total Fee Offsets** | **Total Fee Offsets** | **Total Fee Offsets** |  |  |  | $0.00 |
| **Net Fee Due** | **Net Fee Due** | **Net Fee Due** | **Net Fee Due** |  |  |  | $349.08 |

---

(1) This
 Registration Statement also shall be deemed to cover an indeterminate number of additional shares of Common Stock which may be offered
 and issued pursuant to the Plan to prevent dilution resulting from stock splits, stock dividends or similar transactions.

(2) Estimated
 pursuant to Rule 457 under the Securities Act of 1933, as amended, solely for the purpose of computing the registration fee. The
 proposed maximum aggregate price per share is based on $1.81 per share, the average of the high and low prices per share of Common
 Stock, as reported on The Nasdaq Stock Market, Inc. on February 11, 2026.